The U.S. is engaged in a massive effort to vaccinate the bulk of its population against COVID-19. But some states are working faster than others. See how yours is faring.
Legislation adding new protections for patients being sedated for certain medical and dental procedures in outpatient settings cleared the Georgia House of Representatives Monday.
This week’s Medical Minute, discusses how high doses of CBD, a compound found in the cannabis plant, has been found to reduce the accumulation of beta-amyloid plaque in the brain that is a hallmark of Alzheimer’s disease.
A 1950 law allows the government to award contracts that take priority over all others for national defense. During the pandemic, the law has been used to defend the country against the coronavirus.
Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.
In the U.S. South — home to nine of the nation's 12 heaviest states — obesity is playing a role not only in COVID-19 outcomes but in the calculus of the vaccination rollout.
NPR's Ari Shaprio talks with Jefferson County Commissioner Sheila Tyson about how twice as many white Alabamans are getting COVID-19 vaccinations as Black Alabamans. Birmingham is a case in point.
Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits.
In its final days, the Trump administration created a rule that could eliminate thousands of regulations created by the Department of Health and Human Services. A lawsuit is challenging the rule.
Katie Engelhart explores the complexity of physician-assisted death in the book The Inevitable. She says patients seeking to end their own lives sometimes resort to veterinary drugs from overseas.
At work every day, Agnes Boisvert attends to ICU patients "gasping for air" and dying from COVID-19. But communicating that harsh reality to her skeptical community has been a challenge.
Exposing people to a potentially fatal disease could hasten understanding of COVID-19 and development of new vaccines and treatments. But the risks of such studies raise serious ethical questions.
The Code Breaker profiles Jennifer Doudna, a Nobel Prize-winning biochemist key to the development of CRISPR, and examines the technology's exciting possibilities and need for oversight.